Assertio (ASRT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.11 per share a year ago. These figures are ...

This page features the latest Assertio Therapeutics share stories and breaking news. Assess the latest information about the Assertio Therapeutics stock. Our team of expert financial journalists are ...

Assertio Holdings Inc (NASDAQ:ASRT) exceeded $60 million in Rovedon sales, growing their share in the community oncology clinic segment. The company completed and presented the Rovedon same-day dosing ...

Assertio Holdings (NASDAQ:ASRT) just reported results for the first quarter of 2024. Assertio Holdings reported earnings per share of 4 cents. This was above the analyst estimate for EPS of -3 cents.